Reclassification, Thromboembolic, and Major Bleeding Outcomes Using Different Rates of Renal Function in Anticoagulated Patients With Atrial Fibrillation
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Circulation: Cardiovascular Quality and Outcomes
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Reclassification, Thromboembolic, and Major Bleeding Outcomes Using Different Estimates of Renal Function in Anticoagulated Patients With Atrial Fibrillation: Insights From the PREFER-in-AF and PREFER-in-AF Prolongation Registries
Circ Cardiovasc Qual Outcomes 2021 Jun 03;[EPub Ahead of Print], M Rohla, L Pecen, R Cemin, G Patti, JM Siller-Matula, RB Schnabel, K Huber, P Kirchhof, R De CaterinaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.